coaprovel
sanofi winthrop industrie - irbesartan, hydrochlorothiazide - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension. this fixed dose combination is indicated in adult patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone.
coaprovel film-coated tablet 30025mg
sanofi-aventis singapore pte. ltd. - hydrochlorothiazide; irbesartan - tablet, film coated - 25.00mg - hydrochlorothiazide 25.00mg; irbesartan 300.00mg
coaprovel film-coated tablet 15012.5 mg
sanofi-aventis singapore pte. ltd. - hydrochlorothiazide; irbesartan - tablet, film coated - 12.50 mg - hydrochlorothiazide 12.50 mg; irbesartan 150.00 mg
coaprovel film-coated tablet 30012.5 mg
sanofi-aventis singapore pte. ltd. - hydrochlorothiazide; irbesartan - tablet, film coated - 12.50 mg - hydrochlorothiazide 12.50 mg; irbesartan 300.00 mg
coaprovel 150mg/12.5mg tablet
sanofi-aventis (malaysia) sdn. bhd. - irbesartan; hydrochlorothiazide -
coaprovel 300mg/12.5mg tablet
sanofi-aventis (malaysia) sdn. bhd. - hydrochlorothiazide; irbesartan -
coaprovel 300/25mg tablet
sanofi-aventis (malaysia) sdn. bhd. - hydrochlorothiazide; irbesartan -
coaprovel 300mg12.5mg tablets
sanofi - irbesartan; hydrochlorothiazide - tablet - 300mg ; 12.5mg
coaprovel 150mg12.5mg tablets
sanofi - hydrochlorothiazide; irbesartan - tablet - 12.5mg ; 150mg
coaprovel 300mg25mg tablets
sanofi - hydrochlorothiazide; irbesartan - tablet - 25mg ; 300mg